Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis

Author:

Borgia Sergio M.ORCID,Dearden Janet,Yoshida Eric M.,Shafran Stephen D.,Brown Ashley,Ben-Ari Ziv,Cramp Matthew E.,Cooper Curtis,Foxton Matthew,Rodriguez Conrado Fernandez,Esteban Rafael,Hyland Robert,Lu Sophia,Kirby Brian J.,Meng Amy,Markova Svetlana,Dvory-Sobol Hadas,Osinusi Anu O.,Bruck Rafael,Ampuero JavierORCID,Ryder Stephen D.,Agarwal Kosh,Fox Raymond,Shaw David,Haider Shariq,Willems Bernard,Lurie Yoav,Calleja Jose Luis,Gane Edward J.

Funder

Gilead Sciences, Inc

Publisher

Elsevier BV

Subject

Hepatology

Reference24 articles.

1. World Health Organization (WHO). Hepatitis C Fact Sheet. Available from: http://www.who.int/news-room/fact-sheets/detail/hepatitis-c (accessed 18 July 2018).

2. Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis;Fabrizi;Dig Dis Sci,2015

3. Incidence and progression of chronic kidney disease after hepatitis C seroconversion: results from ERCHIVES;Rogal;Dig Dis Sci,2016

4. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies;Fabrizi;J Viral Hepat,2007

5. Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis;Lee;PLoS ONE,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3